Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for reducing blood lipids

A composition and drug technology, applied in the direction of drug combination, active ingredients of hydroxyl compounds, active ingredients of heterocyclic compounds, etc., can solve the problems of few targets, lack of links, and high cost of health food, so as to achieve sufficient raw material sources, lower blood lipids, low cost effect

Inactive Publication Date: 2010-03-17
BEIJING LIQIANQIU SCI & TECH DEV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] There are many types of medicines or health foods currently used to lower blood lipids, but there are many drugs with side effects, and there are few health food targets and links, which need to be improved, and the cost is high, and the price is high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for reducing blood lipids

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Seabuckthorn 800mg,

[0029] Vitamin B 1 3 mg,

[0030] Vitamin B 2 3 mg,

[0031] Vitamin B 6 2 mg,

[0032] Niacinamide 10mg,

[0033] Vitamin C 30mg,

[0034] Zinc lactate (calculated as trace element zinc) 10mg,

[0035] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0036] Chromium picolinate (calculated as trace element chromium) 0.01mg,

[0037] Sodium molybdate (calculated as trace element molybdenum) 0.03mg,

[0038] Magnesium lactate (calculated as elemental magnesium) 200mg,

[0039] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0040] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to obtain 9 capsules, 3 times a day, 3 capsules each time .

Embodiment 2

[0042] Seabuckthorn 1500mg,

[0043] Vitamin B 1 3 mg,

[0044] Vitamin B 2 3 mg,

[0045] Vitamin B 6 2 mg,

[0046] Niacinamide 10mg,

[0047] Vitamin C 30mg,

[0048] Zinc lactate (calculated as trace element zinc) 8mg,

[0049] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0050] Chromium yeast (calculated as trace element chromium) 0.02mg,

[0051] Sodium molybdate (calculated as trace element molybdenum) 0.04mg,

[0052] Calcium lactate (calculated as elemental calcium) 600mg,

[0053] Magnesium lactate (calculated as elemental magnesium) 200mg,

[0054] Vitamin D 0.002mg,

[0055] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0056] The above components were further uniformly mixed with appropriate amounts of additives such as magnesium aluminosilicate, polysolvate 60 and propylene glycol, and the resulting mixture was evenly filled into capsules to o...

Embodiment 3

[0058] Seabuckthorn 2500mg,

[0059] Vitamin B 1 3 mg,

[0060] Vitamin B 2 3 mg,

[0061] Vitamin B 6 2 mg,

[0062]Folic acid 0.3mg,

[0063] Vitamin B 12 0.003mg,

[0064] Niacinamide 10mg,

[0065] Vitamin C 30mg,

[0066] Zinc lactate (calculated as trace element zinc) 10mg,

[0067] Sodium selenate (calculated as trace element selenium) 0.02mg,

[0068] Chromium yeast (calculated as trace element chromium) 0.02mg,

[0069] Sodium molybdate (calculated as trace element molybdenum) 0.03mg,

[0070] Calcium lactate (calculated as elemental calcium) 600mg,

[0071] Magnesium lactate (calculated as elemental magnesium) 200mg,

[0072] Vitamin D 0.002mg,

[0073] Vitamin E (calculated as α-tocopherol equivalent) 10mg α-TE.

[0074] The above components were further uniformly mixed with an appropriate amount of additives such as magnesium aluminosilicate, polysolvate 6...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Retinol equivalentaaaaaaaaaa
Login to View More

Abstract

The invention relates to a pharmaceutical composition for reducing blood lipids, and the composition comprises seabuckthorn, vitamin A, beta-carotene, compound vitamin B, vitamin C, vitamin D, vitaminE, and macro elements such as calcium and magnesium and trace elements such as zinc, selenium, chromium and molybdenum. The pharmaceutical composition is mainly applicable to people with high blood lipids and very effective in the aspect of reducing the blood lipids, and can be applied for a long time or be applied according to the course of treatment.

Description

Technical field: [0001] The invention relates to the technical field of medicine and health products; especially a pharmaceutical composition for lowering blood fat. Background technique: [0002] The composition comprises seabuckthorn, vitamin A, beta-carotene, complex vitamin B, vitamin C, vitamin D, vitamin E, macroelements calcium, magnesium and trace elements zinc, selenium, chromium and molybdenum. [0003] Seabuckthorn is a natural Chinese medicinal material that is both food and medicine. It has the effects of invigorating the spleen and eliminating food, eliminating phlegm and relieving cough, promoting blood circulation and removing blood stasis; it is clinically used to treat spleen deficiency, less food, cough with excessive phlegm, blood stasis and amenorrhea, and bruises and bruises and other diseases; modern pharmacological studies have confirmed that seabuckthorn has: 1. Lowering blood fat; 2. Protecting liver; 3. Anti-tumor effect; 4. Anti-oxidation and anti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/185A61P3/06A61K31/015A61K31/07A61K31/191A61K31/197A61K31/355A61K31/375A61K31/4188A61K31/4415A61K31/455A61K31/51A61K31/519A61K31/525A61K31/59A61K31/714A61K33/04A61K33/24
Inventor 陈欣晶
Owner BEIJING LIQIANQIU SCI & TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com